Skip to main content
Dhanuka Agritech Ltd. logo

Dhanuka Agritech Ltd. — Investor Relations & Filings

Ticker · DHANUKA ISIN · INE435G01025 LEI · 335800E4DLZIC7MSG125 BSE.NS Manufacturing
Filings indexed 1,595 across all filing types
Latest filing 2025-10-16 Regulatory Filings
Country IN India
Listing BSE.NS DHANUKA

About Dhanuka Agritech Ltd.

https://www.dhanuka.com/

Dhanuka Agritech Ltd. specializes in the manufacturing and marketing of a comprehensive range of crop protection solutions, including insecticides, herbicides, fungicides, and plant growth regulators. The company maintains strategic technical collaborations with several global chemical innovators to bring advanced formulations to the agricultural sector. Its product portfolio is supported by a robust research and development infrastructure and an extensive distribution network that facilitates the delivery of integrated pest management and soil health solutions. The organization focuses on enhancing agricultural productivity through the provision of high-quality inputs and technical advisory services. By leveraging a strong field force, it provides training and support to optimize crop yields and resource efficiency, ensuring the effective application of its diverse chemical and biological offerings.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is an intimation to stock exchanges about a scheduled conference call with analysts and investors to discuss the unaudited financial results for the quarter and half-year ended 30th September 2025. It includes details about the call timing, participants, and dial-in information. The document does not contain the financial results themselves, nor detailed financial statements or analysis. It is an announcement of a conference call related to financial results, not the transcript or the results report itself. Therefore, the document fits the category of a Call Transcript (CT) announcement or invitation. However, since it is only an intimation about the call and not the transcript, it is best classified as a Regulatory Filing (RNS) as a general regulatory announcement about the call. Given the document length and content, confidence is high.
2025-10-16 English
Intimation with respect to Conference Call with Analysts/ Investors to discuss Un-audited Financial Results of the Company for the Quarter and Half-Year Ended on 30th September 2025
Call Transcript Classification · 90% confidence The document is an intimation to stock exchanges about a scheduled conference call with analysts and investors to discuss the unaudited financial results for the quarter and half-year ended 30th September 2025. It includes details about the call timing, participants, and dial-in information. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a notification about a conference call related to financial results, not the transcript or the results report itself. Therefore, it fits the category of a Call Transcript (CT) announcement or invitation. However, since it is only an announcement of the call and not the transcript, and given the options, the best fit is Call Transcript (CT) as it relates directly to the conference call with investors discussing financial results.
2025-10-16 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-10-16 English
Board Meeting — Financial Results
Board/Management Information Classification · 95% confidence The document is a notice from the company to stock exchanges about an upcoming Board of Directors meeting scheduled for October 31, 2025. The purpose of the meeting is to consider and approve financial results for the quarter and half-year ending September 30, 2025. The document references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, and mentions the closure of the trading window for insiders. The document is a notification of a board meeting and not the actual financial results or report. It is also short (1633 characters) and serves as an announcement rather than a report. Therefore, it fits the category of Board/Management Information (MANG), which includes announcements of board meetings and related management information.
2025-10-16 English
Dhanuka Agritech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 ,inter alia, to consider and approve the un-audited Financial Results ....
Regulatory Filings Classification · 95% confidence The document is a notice from the company to stock exchanges about an upcoming Board of Directors meeting scheduled for 31st October 2025. The purpose of the meeting is to consider and approve the financial results for the quarter and half-year ending 30th September 2025. The document references compliance with SEBI regulations and mentions the trading window closure for insiders. The document is short (1633 characters) and serves as an announcement of a future event (board meeting) rather than containing any financial results or detailed report. It does not contain actual financial data or detailed management discussion. Therefore, it is best classified as a Regulatory Filing (RNS) as it is a general regulatory announcement and does not fit into other specific categories like Interim Report or Earnings Release.
2025-10-16 English
Compliance under Regulation 74(5) of the SEBI (Depository and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 74(5) of the SEBI (Depository and Participants) Regulations, 2018, for the quarter ended 30th September 2025. It is a letter from the Registrar and Share Transfer Agent confirming dematerialization and listing compliance. The document is short (2832 characters) and serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements or detailed financial data. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for compliance certificates and miscellaneous regulatory announcements.
2025-10-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.